Cell Therapeutics, Inc. (CTI) Announces ASCO Activities
May 29th, 2007
Cell Therapeutics, Inc. (CTI)Â today announced presentations of interest on lung cancer and on its development candidate XYOTAX(TM) (paclitaxel poliglumex) at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting, being held June 1-5, 2007, in Chicago.

